TABLE 1.
Subjecta | No. of days of observation | Isolate | No. of initial papules | Final outcome after initial papule formation
|
||
---|---|---|---|---|---|---|
No. of papules | No. of pustules | No. resolved | ||||
186 | 6 | 35000HP | 2 | 2 | ||
35000HP-sodC-cat | 1 | 1 | ||||
187 | 9 | 35000HP | 2 | 2 | ||
35000HP-sodC-cat | 3 | 3 | ||||
188 | 9 | 35000HP | 2 | 1 | 1 | |
35000HP-sodC-cat | 3 | 1 | 2 | |||
190 | 10 | 35000HP | 2 | 1 | 1 | |
35000HP-sodC-cat | 3 | 2 | 1 | |||
191 | 7 | 35000HP | 2 | 1 | 1 | |
35000HP-sodC-cat | 3 | 3 | ||||
192 | 7 | 35000HP | 2 | 2 | ||
35000HP-sodC-cat | 3 | 3 |
Each volunteer was inoculated at two sites with the parent (35000HP) and at three sites with the mutant (35000HP-sodC-cat). Volunteers 186, 187, and 188 were inoculated in the first iteration, and volunteers 190, 191, and 192 were inoculated in the second iteration.